- €63.33bn
- €71.64bn
- €21.10bn
Brief: Pharma Mar's Partner Merck Submits Application For Lung Cancer Drug Zepzelca In Japan
Europe Research Roundup: ASML Holding, Douglas, Richemont
European shares lifted by miners and tech; Mideast in focus (updated)
Merck jumps as lab demand lifts 2026 outlook
Brief: Merck Enters Five-Year Agreement To Provide End-To-End Testing Services For Genetix Biotherapeutics' Commercial Therapies
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
India's Sun Pharma to buy Organon in $11.75 billion all-cash deal (updated)
Merck, rivals eye Inhibrx experimental cancer drug tied to Keytruda, sources say
Inhibrx rises as experimental drug tied to Merck’s Keytruda catches drugmakers' eye
Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Analysis: TrumpRx lists many medicines at prices higher than paid in UK
Europe Research Roundup: Basic-Fit, ENI, Neste
Merck to expand China investment, Xinhua reports
Merck KGaA drops after outlook 2026, stable dividend 'disappoint'
Merck KGaA sees earnings decline on forex headwinds, MS drug (updated)
Merck KGaA sees earnings decline of up to 4%
Analysis: Sanofi's new CEO needs to fix drug pipeline and navigate Trump
Press Digest: Financial Times - February 13